Results 61 to 70 of about 2,966 (119)

Competitive LC-MS/MS assay to investigate protein metalation dynamics.

Inorg Chem Front
Küssner K, Wolf M, Cucchiaro A, Hartinger CG, Meier-Menches S, Cziferszky M.   +5 more
europepmc   +1 more source

STRATEGIC-1: multiple-line, randomized, open-label GERCOR-PRODIGE-39 phase III trial in unresectable RAS/BRAF wild-type metastatic colorectal cancer. [PDF]

Signal Transduct Target Ther
Chibaudel B, Dourthe LM, André T, Henriques J, Bourgeois V, Etienne PL, Desramé J, Carola E, Dupuis O, Baba-Hamed N, Auby D, Louvet C, Maillard E, Romano O, Tournigand C, Garcia-Larnicol ML, Shacham-Shmueli E, Bird BH, Ghiringhelli F, de Gramont A.   +19 more
europepmc   +1 more source

Studies on the Complexation of Platinum(II) by Some 4-Nitroisothiazoles and the Cytotoxic Activity of the Resulting Complexes. [PDF]

Molecules
Regiec A, Wietrzyk J, Milczarek M, Kochel A, Mastalarz H.   +4 more
europepmc   +1 more source

Neoadjuvant chemoradiotherapy plus sintilimab in proficient mismatch repair locally advanced rectal cancer with intermediate/high-immunoscore (SILAR): a single-arm phase II trial. [PDF]

Nat Commun
Zheng X, Liu H, Shi L, Zeng Z, Zhang X, Luo S, Cai Y, Li Z, Liu Z, Hou Y, Yang Z, He X, Ke J, Huang L, Luo Y, Kang L.   +15 more
europepmc   +1 more source

Neoadjuvant FOLFOXIRI plus bevacizumab without radiotherapy for high-risk rectal cancer: multicentre phase II trial. [PDF]

BJS Open
Matsuda T, Nagatani Y, Funakoshi Y, Tsuboyama T, Mii Y, Kaneda K, Tanaka T, Hasegawa H, Yamashita K, Kiyota N, Minami H, Kakeji Y.   +11 more
europepmc   +1 more source

Click-Controlled Photo-Uncaging: Click-Assembly of Platinum-Based Photoactive Protecting Groups for Light-Triggered Bioactive Molecule Release. [PDF]

J Am Chem Soc
Sharma A, Jogadi W, Kshetri M, Alqarni S, Amin MA, Cheline M, Pokhrel B, Akter S, Lin Z, Park J, Solmen J, Caraway J, Brattley M, Shen H, Zheng YR.   +14 more
europepmc   +1 more source

A Targeted Redox-Active Dual-Action Pt(IV)-Mn(II) Prodrug Displays Enhanced In Vivo Anticancer Activity. [PDF]

Adv Healthc Mater
Lopez-Sanchez A, Chédotal H, Muthuramalingam RPK, Thomas M, Yau JNN, Sahoo PR, Policar C, Batteux F, Medjoubi K, Somogyi A, Adriani G, Nicco C, Coriat R, Pastorin G, Bertrand HC.   +14 more
europepmc   +1 more source

Targeting FBXL5 to induce ferroptosis and reverse oxaliplatin resistance in iron-rich colorectal cancer. [PDF]

Sci Rep
Wang M, Zhang R, He S, Wen F, Yu X, Xu X, Li Y, Wu S.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Organoplatinum compounds VII

Journal of Organometallic Chemistry, 1998
Abstract The structural chemistry of organoplatinum clusters [Me3PtX]4 (X=halide) has been completed with the synthesis and X-ray investigation of [Me3PtF]4 (1) and its structural comparison to the well-known hydroxide [Me3PtOH]4 (2), all members of the ‘organoplatinum cubane’ family.
H Donath, E.V Avtomonov, I Sarraje, K.-H von Dahlen, M El-Essawi, J Lorberth, B.-S Seo   +6 more
exaly   +2 more sources